NZ204393A - Pharmaceutical compositions containing polyfluoroalcohols - Google Patents
Pharmaceutical compositions containing polyfluoroalcoholsInfo
- Publication number
- NZ204393A NZ204393A NZ204393A NZ20439383A NZ204393A NZ 204393 A NZ204393 A NZ 204393A NZ 204393 A NZ204393 A NZ 204393A NZ 20439383 A NZ20439383 A NZ 20439383A NZ 204393 A NZ204393 A NZ 204393A
- Authority
- NZ
- New Zealand
- Prior art keywords
- pharmaceutical composition
- composition according
- formula
- weight
- polyfluoroalcohols
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C31/00—Saturated compounds having hydroxy or O-metal groups bound to acyclic carbon atoms
- C07C31/34—Halogenated alcohols
- C07C31/38—Halogenated alcohols containing only fluorine as halogen
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT8221553A IT8221553A0 (it) | 1982-05-28 | 1982-05-28 | Composizioni farmaceutiche adattivita' antineoplastica. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ204393A true NZ204393A (en) | 1986-03-14 |
Family
ID=11183507
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ204393A NZ204393A (en) | 1982-05-28 | 1983-05-27 | Pharmaceutical compositions containing polyfluoroalcohols |
Country Status (16)
| Country | Link |
|---|---|
| JP (1) | JPS591414A (it) |
| AU (2) | AU552557B2 (it) |
| BE (1) | BE896838A (it) |
| CH (1) | CH653890A5 (it) |
| DE (1) | DE3319304A1 (it) |
| FR (1) | FR2527439A1 (it) |
| GB (1) | GB2121280B (it) |
| IE (1) | IE55137B1 (it) |
| IL (1) | IL68796A0 (it) |
| IN (1) | IN157042B (it) |
| IT (1) | IT8221553A0 (it) |
| LU (1) | LU84827A1 (it) |
| NL (1) | NL8301899A (it) |
| NZ (1) | NZ204393A (it) |
| SE (1) | SE8302976L (it) |
| ZA (1) | ZA833871B (it) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3836971C1 (it) | 1988-10-31 | 1990-05-17 | Weck, Wolfgang, Dr.Med., 6990 Bad Mergentheim, De |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3219004C1 (de) * | 1982-05-19 | 1984-03-01 | Philippine Dr. 8000 München Hartmann | Arzneimittel zur Behandlung von Tumoren |
-
1982
- 1982-05-28 IT IT8221553A patent/IT8221553A0/it unknown
-
1983
- 1983-05-20 CH CH2772/83A patent/CH653890A5/it not_active IP Right Cessation
- 1983-05-26 GB GB08314540A patent/GB2121280B/en not_active Expired
- 1983-05-26 BE BE2/60100A patent/BE896838A/nl not_active IP Right Cessation
- 1983-05-26 AU AU15000/83A patent/AU552557B2/en not_active Expired - Fee Related
- 1983-05-26 IL IL68796A patent/IL68796A0/xx unknown
- 1983-05-26 SE SE8302976A patent/SE8302976L/ not_active Application Discontinuation
- 1983-05-26 JP JP58093889A patent/JPS591414A/ja active Pending
- 1983-05-27 NZ NZ204393A patent/NZ204393A/en unknown
- 1983-05-27 NL NL8301899A patent/NL8301899A/nl not_active Application Discontinuation
- 1983-05-27 ZA ZA833871A patent/ZA833871B/xx unknown
- 1983-05-27 IE IE1259/83A patent/IE55137B1/en unknown
- 1983-05-27 FR FR8308776A patent/FR2527439A1/fr not_active Withdrawn
- 1983-05-27 DE DE19833319304 patent/DE3319304A1/de not_active Ceased
- 1983-05-27 LU LU84827A patent/LU84827A1/fr unknown
- 1983-05-27 IN IN673/CAL/83A patent/IN157042B/en unknown
-
1988
- 1988-05-04 AU AU15570/88A patent/AU1557088A/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| GB8314540D0 (en) | 1983-06-29 |
| IT8221553A0 (it) | 1982-05-28 |
| ZA833871B (en) | 1984-07-25 |
| LU84827A1 (fr) | 1983-11-17 |
| GB2121280B (en) | 1985-08-29 |
| FR2527439A1 (fr) | 1983-12-02 |
| IE55137B1 (en) | 1990-06-06 |
| AU1500083A (en) | 1983-12-01 |
| AU552557B2 (en) | 1986-06-05 |
| GB2121280A (en) | 1983-12-21 |
| DE3319304A1 (de) | 1983-12-01 |
| CH653890A5 (it) | 1986-01-31 |
| SE8302976L (sv) | 1983-11-29 |
| SE8302976D0 (sv) | 1983-05-26 |
| IE831259L (en) | 1983-11-28 |
| JPS591414A (ja) | 1984-01-06 |
| IN157042B (it) | 1986-01-04 |
| AU1557088A (en) | 1988-11-10 |
| BE896838A (nl) | 1983-09-16 |
| NL8301899A (nl) | 1983-12-16 |
| IL68796A0 (en) | 1983-09-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2356547C2 (ru) | Способы лечения рака с использованием ингибиторов hdac | |
| FARBER et al. | The influence of sex and of testosterone upon fatty liver due to ethionine | |
| EP0139534B1 (en) | Compositions for the prophylactic treatment of osteitis and osteomyelitis | |
| Hodge et al. | Toxicity of sodium cyanurate | |
| Kothari et al. | Pineal ablation in varying photoperiods and the incidence of 9, 10-dimethyl-1, 2-benzanthracene induced mammary cancer in rats | |
| Tadlock et al. | Protection of mice against the lethal effects of sodium arsenite by 2, 3 dimercapto-1-propane-sulfonic acid and dimercaptosuccinic acid | |
| RU2005135428A (ru) | Поглощение макромолекул | |
| US6071888A (en) | Composition for treating cancer | |
| WO1986003968A1 (en) | Proglumide and pharmaceutical compositions containing it for use in the treatment of neoplastic affections | |
| NZ204393A (en) | Pharmaceutical compositions containing polyfluoroalcohols | |
| McIver | Increased susceptibility to chloroform poisoning produced in the albino rat by injection of crystalline thyroxin | |
| Osmond et al. | The action of batyl alcohol and selachyl alcohol on the one marrow of the Guinea pig | |
| JPH06501449A (ja) | 癌またはウイル性疾患の治療におけるトリニトロベンゼン類またはカルミン酸の使用 | |
| Kraml et al. | Gastrointestinal Absorption of Griseofulvin: Levels in the Serum of Human Patients on Prolonged BID Administration of Micronized and Common Griseofulvin | |
| McCormick | Anticarcinogenic activity of quinacrine in the rat mammary gland | |
| Srivastava et al. | Polyherbal preparation for anti-diabetic activity: a screening study | |
| Pera Jr et al. | Effects of mannitol or furosemide diuresis on cis-dichlorodiammineplatinum (II) antitumor activity and toxicity to host-renewing cell populations in rats | |
| Usenik et al. | Effect of Barbiturate Anesthetics on Leukocytes in normal and splenectomized dogs | |
| Gauthier et al. | Histamine sensitivity of adrenalectomized and pertussis-treated mice | |
| Cohen et al. | Experimental evaluation of systemic medication (cysteamine, menadione, flavonoids and corticoids) modifying reactions to radiotherapy | |
| WO2001080871A2 (de) | Anwendung von guanylat-zyklase-c (gc-c) agonisten als insulinotrope faktoren zur behandlung von diabetes mellitus typ 2 | |
| EP0392662B1 (en) | Use of complexes of tetrachloroplatinate with a diazo dye as antitumour agents | |
| DE2221281C3 (de) | Pharmazeutische Zubereitungen mit entzündungshemmender und analgetischer Wirkung | |
| US3222253A (en) | Antimitotic colchicines | |
| Reznik et al. | Protective effect of anti-inflammatory corticosteroid triamcinolone in cisplatin nephrotoxicity |